Black Diamond Therapeutics (BDTX) Treasury Shares (2018 - 2026)
Black Diamond Therapeutics (BDTX) posted Treasury Shares of $225000.0 for Q1 2026, down 50.0% on a QoQ basis from $450000.0 in Q4 2025, and down 77.27% year-over-year from $990000.0 in Q1 2025.
Black Diamond Therapeutics (BDTX) Treasury Shares (2018 - 2026) Analysis & Trends
Black Diamond Therapeutics' Treasury Shares history runs 9 years deep, the most recent figure standing at $225000.0 for Q1 2026.
- Quarterly Treasury Shares fell 77.27% year-over-year to $225000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $225000.0 (down 77.27% YoY) and the FY2025 annual result came in at $450000.0, down 16.67% from the prior year.
- Treasury Shares was $225000.0 for Q1 2026 at Black Diamond Therapeutics, down from $450000.0 in the prior quarter.
- Across five years, Treasury Shares topped out at $990000.0 in Q1 2025 and bottomed at $19000.0 in Q4 2023.
- A 5-year average of $281181.4 and a median of $225000.0 in 2026 frame the typical range for Treasury Shares.
- Annual changes were most pronounced in 2024 — Treasury Shares plunged 91.5% — and 2025, when it soared 4964.2%.
- Black Diamond Therapeutics' Treasury Shares stood at $101397.0 in 2022, then plunged by 81.26% to $19000.0 in 2023, then surged by 2742.11% to $540000.0 in 2024, then decreased by 16.67% to $450000.0 in 2025, then plunged by 50.0% to $225000.0 in 2026.
- Business Quant data shows BDTX's Treasury Shares at $225000.0 in Q1 2026, $450000.0 in Q4 2025, and $670000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | -21,709.08 |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | 265,401.92 |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | - |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | 19.41 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | 5.14 Mn |
| 10 | Black Diamond Therapeutics | 99.59 Mn | -18.67 Mn | - | 225,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 225,000.00 |
| Mar 31, 2026 | 225,000.00 |
| Dec 31, 2025 | 450,000.00 |
| Dec 31, 2025 | 450,000.00 |
| Sep 30, 2025 | 670,000.00 |
| Sep 30, 2025 | 670,000.00 |
| Jun 30, 2025 | 670,000.00 |
| Jun 30, 2025 | 670,000.00 |
| Mar 31, 2025 | 990,000.00 |
| Mar 31, 2025 | 990,000.00 |
| Dec 31, 2024 | 540,000.00 |
| Dec 31, 2024 | 540,000.00 |
| Sep 30, 2024 | 19,000.00 |
| Sep 30, 2024 | 19,000.00 |
| Jun 30, 2024 | 19,000.00 |
| Jun 30, 2024 | 19,000.00 |
| Mar 31, 2024 | 19,549.00 |
| Mar 31, 2024 | 19,549.00 |
| Dec 31, 2023 | 19,000.00 |
| Dec 31, 2023 | 19,000.00 |